When a rarely traded nano-cap stock rises sharply on the back of positive news, then it becomes a major story in the markets. This is exactly what happened to Can-Fite Biopharma (NYSE:CANF). In a new development, CANF stock went on a remarkable rally this morning.
Major BoostCan-Fite Biopharma is involved in manufacturing medicines meant for the treatment of rheumatoid arthritis (RA), and today, a major conference on this topic is happening in Austria. It is going to be attended by some of the best-known experts on the subject and will be held at the headquarters ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.